Point72 Asset Management
MIST icon

Point72 Asset Management’s Milestone Pharmaceuticals MIST Stock Holding History

Point72 Asset Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29M Buy
1,085,683
+603,328
+125% +$1.06M ﹤0.01% 2592
2025
Q4 		$974K Buy
+482,355
New +$1.04M ﹤0.01% 2891
2023
Q3 		– Sell
-232,659
Closed -$663K – 2724
2023
Q2 		$663K Sell
232,659
-1,042,341
-82% -$3.93M ﹤0.01% 1208
2023
Q1 		$5.02M Buy
1,275,000
+400,000
+46% +$1.46M 0.02% 751
2022
Q4 		$3.46M Buy
+875,000
New +$4.61M 0.01% 835

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Point72 Asset Management's MIST Position: Q1 2026 in Review

Point72 Asset Management increased its Milestone Pharmaceuticals (MIST) stake by 125% in Q1 2026, buying an estimated $1.06M and bringing the position to 1,085,683 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2592.

Point72 Asset Management first reported a position in MIST in Q4 2022 and has held it in 5 quarters since. The position peaked at $5.02M in Q1 2023. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Point72 Asset Management held 1,085,683 shares of Milestone Pharmaceuticals worth $1.29M as of Q1 2026.
  • Point72 Asset Management bought 603,328 Milestone Pharmaceuticals shares in Q1 2026, an estimated $1.06M.
  • Milestone Pharmaceuticals made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #2592 holding.
  • Point72 Asset Management first reported a position in Milestone Pharmaceuticals in Q4 2022 and has held it in 5 quarters since.
  • Point72 Asset Management's Milestone Pharmaceuticals position peaked at $5.02M in Q1 2023.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.